BLRX

BioLineRx Share Price

3.78
0.03 (0.8%)
3.78
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
BioLineRx Ltd BLRX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.03 0.8% 3.78 07:54:51
Open Price Low Price High Price Close Price Prev Close
3.75
Bid Price Ask Price Spread News
3.77 3.79 0.02 - -
Trades Volume Avg Volume 52 Week Range
1,278 232,401 9,519,022 1.40 - 6.34
Last Trade Time Type Quantity Stock Price Currency
07:53:53 formt 268  3.78 USD

BioLineRx Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 162.66M 43.03M 43.03M  -  - -1.95 -1.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News BioLineRx

Date Time Source Heading
5/04/202108:26Seeking AlphaBioLineRx (BLRX) shares rocket 73% on positive Motixafortide..
5/04/202107:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/15/202116:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/05/202116:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/26/202116:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/25/202106:05Edgar (US Regulatory)Notice of Effectiveness (effect)
2/23/202109:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

BLRX Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

BioLine Rx Ltd is a clinical-stage biopharmaceutical development company with a strategic focus on oncology. Its development and commercialization pipeline consists of two clinical-stage therapeutic candidates - Motixafortide, a novel peptide for the treatment of solid tumors, hematological malignancies and stem cell mobilization, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, it has an off- strategy, a legacy therapeutic product called BL-5010 for the treatment of skin lesions.
Your Recent History
NASDAQ
BLRX
BioLineRx
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210506 12:09:52